Sci Rep 13(1) Meloni AR, Deyoung MB, Lowe C, Parkes DG (2013) GLP-1 receptor activated insulin secretion from pancreatic -cells: mechanism and glucose dependence
Several states are dropping weight loss coverage of GLP-1s from their version of Medicaid, including California's Medi-cal program
It is of interest that children with Prader-Willi syndrome, which exhibit hyperphagia and obesity have a low level of plasma PP and infusion of PP in those children leads to reduction in food intake (63)
Track: Weekly weight (same day, same time, same conditions) Measurements (waist, hips, chestmore reliable than scale alone) Side effects (what you feel, when, how severe) Food intake (even rough estimates help) PeptIQ makes this simplelog doses, track inventory, monitor your response over time
Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial